heart iconheart icon
Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Apr 17, 2018
NEW BRUNSWICK, N.J., April 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $20.0 billion for the first quarter of 2018, an increase of 12.6% as compared to the first quarter of 2017. Operational sales results increased 8.4% and the positive impact of currency was 4.2%. Domestic sales increased 6.1%. International sal...
Apr 16, 2018
Apr 12, 2018
Apr 11, 2018
JACKSONVILLE, Fla., April 11, 2018 /PRNewswire/ -- Johnson & Johnson Vision today announced ACUVUE OASYS® with Transitions® Light Intelligent Technology™ first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the ey...
Mar 20, 2018
NEW BRUNSWICK, N.J., March 20, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that Dominic J. Caruso, Executive Vice President, Chief Financial Officer, has elected to retire in September 2018 after a distinguished 19-year career with the Company.  Caruso was named CFO in 2007, and served as CFO longer than anyone in the company...
Mar 20, 2018
NEW BRUNSWICK, N.J., March 20, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 17, to review first-quarter results. Dominic Caruso, Executive Vice President, Chief Financial Officer; Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals...
Mar 16, 2018
NEW BRUNSWICK, N.J., March 16, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan, Inc. is a leader in blood glucose monitoring prod...
Mar 15, 2018
Mar 11, 2018
Mar 7, 2018
WASHINGTON, March 7, 2018 /PRNewswire/ -- Today, Peter Menziuso and Carol Lakkis, BScOptom, Ph.D., represented Johnson & Johnson Vision alongside fellow eye health advocates in Washington, D.C. to underscore the company's commitment to eye health and patient safety during the Federal Trade Commission's (FTC) public workshop. ...
Page:
1
... NextLast
= add release to Briefcase